Efficacy of Magnesium Supplementation in Functional Constipation: A Systematic Review.
4 affiliations
- 1Medical School, Royal College of Surgeons in Ireland - Bahrain, Busaiteen, BHR.
- 2Medical School, Faculty of Medicine, Mansoura University, Mansoura, EGY.
- 3Anatomy, Royal College of Surgeons in Ireland - Bahrain, Busaiteen, BHR.
- 4Biochemistry, Royal College of Surgeons in Ireland - Bahrain, Busaiteen, BHR.
Abstract
Magnesium supplementation has been proposed as a therapeutic option for functional constipation due to its osmotic properties, role in smooth muscle contraction, and influence on aquaporin-3 expression; however, the evidence has not been systematically synthesized. This review assessed whether magnesium supplementation, in any formulation, improves stool frequency, stool consistency, or quality of life in patients of any age with functional constipation, compared with placebo, standard care, or an active comparator. A systematic search of PubMed, Scopus, Web of Science, EMBASE, and CINAHL was conducted over a 10-year period to December 2025. Study quality was assessed utilizing the Mixed Methods Appraisal Tool. Due to substantial heterogeneity in the studies, a narrative synthesis was performed. This review was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. The certainty of the evidence was not formally graded. Seven studies (n = 690) met the inclusion criteria, addressing functional constipation across infant, pediatric, and adult populations. Five were randomized controlled trials, and two were nonrandomized studies. Four of seven studies showed statistically significant between-group improvements in stool frequency. Six studies reported stool consistency numerically, with statistically significant between-group differences in four; the remaining studies showed either within-group improvement or no significant differences between groups. Constipation-specific quality-of-life testing was assessed using a validated instrument in only two studies, both of which showed significant between-group improvement. Magnesium oxide was the most commonly used formulation in adults. No serious adverse events were reported in any trial, although adverse event reporting was inconsistent across studies. The findings suggest that magnesium supplementation, primarily magnesium oxide, may improve outcomes in functional constipation, but are not sufficient to support a treatment recommendation. The findings relate to magnesium oxide and cannot be assumed to apply to other forms of magnesium supplementation. The evidence base is limited by small sample sizes, heterogeneous study designs, and confounded interventions. Double-blind, placebo-controlled trials with standardized outcomes are needed to further explore this domain.
Related
- Nursing interventions for pediatric functional constipation: a systematic review of evidence and clinical implications
- Mechanisms of Magnesium Transport Through Cell Membranes: The Primacy of the Free Divalent Cation and Implications for Magnesium Supplementation
- Efficacy of sodium-glucose cotransporter-2 inhibitors on functional mitral regurgitation associated with heart failure: a systematic review and meta-analysis of randomized controlled trials
- Nurse-led rehabilitation after total hip or knee arthroplasty: a systematic review and meta-analysis of functional recovery, self-efficacy, and quality of life.
- Primitive reflex profiles and sensorimotor intervention in children with functional constipation and fecal retention
BibTeX
@article{kadhem2026efficacy,
title = {{Efficacy of Magnesium Supplementation in Functional Constipation: A Systematic Review.}},
author = {Hasan Kadhem and Ward Alasfoor and Mohamed Saeed Ali and Talal Sarhan and Vijayalakshmi S Bhojaraja and Jeevan K Shetty},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.116715},
url = {https://europepmc.org/article/MED/42923351},
note = {CC BY},
}
RIS
TY - JOUR
TI - Efficacy of Magnesium Supplementation in Functional Constipation: A Systematic Review.
AU - Hasan Kadhem
AU - Ward Alasfoor
AU - Mohamed Saeed Ali
AU - Talal Sarhan
AU - Vijayalakshmi S Bhojaraja
AU - Jeevan K Shetty
PY - 2026
DA - 2026/09/22
JO - Cureus
DO - 10.7759/cureus.116715
UR - https://europepmc.org/article/MED/42923351
AB - Magnesium supplementation has been proposed as a therapeutic option for functional constipation due to its osmotic properties, role in smooth muscle contraction, and influence on aquaporin-3 expression; however, the evidence has not been systematically synthesized. This review assessed whether magnesium supplementation, in any formulation, improves stool frequency, stool consistency, or quality of life in patients of any age with functional constipation, compared with placebo, standard care, or an active comparator. A systematic search of PubMed, Scopus, Web of Science, EMBASE, and CINAHL was conducted over a 10-year period to December 2025. Study quality was assessed utilizing the Mixed Methods Appraisal Tool. Due to substantial heterogeneity in the studies, a narrative synthesis was performed. This review was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. The certainty of the evidence was not formally graded. Seven studies (n = 690) met the inclusion criteria, addressing functional constipation across infant, pediatric, and adult populations. Five were randomized controlled trials, and two were nonrandomized studies. Four of seven studies showed statistically significant between-group improvements in stool frequency. Six studies reported stool consistency numerically, with statistically significant between-group differences in four; the remaining studies showed either within-group improvement or no significant differences between groups. Constipation-specific quality-of-life testing was assessed using a validated instrument in only two studies, both of which showed significant between-group improvement. Magnesium oxide was the most commonly used formulation in adults. No serious adverse events were reported in any trial, although adverse event reporting was inconsistent across studies. The findings suggest that magnesium supplementation, primarily magnesium oxide, may improve outcomes in functional constipation, but are not sufficient to support a treatment recommendation. The findings relate to magnesium oxide and cannot be assumed to apply to other forms of magnesium supplementation. The evidence base is limited by small sample sizes, heterogeneous study designs, and confounded interventions. Double-blind, placebo-controlled trials with standardized outcomes are needed to further explore this domain.
SN - 2168-8184
ER -